Product correctly added to cart.

discount label
Bortezomib intermediate I
View 3D

Biosynth logo

Bortezomib intermediate I

CAS: 1248339-44-7

Ref. 3D-II160938

1mg
73.00 €
5mg
196.00 €
10mg
235.00 €
25mg
386.00 €
50mg
491.00 €
Estimated delivery in United States, on Friday 26 Jul 2024

Product Information

Name:
Bortezomib intermediate I
Synonyms:
  • [[1,1'-(Imino-κN)bis[2-propanolato-κO]](2-)][3-methyl-1-[[1-oxo-3-phenyl -2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-(T-4)-boron
Description:

Bortezomib intermediate I is a metabolite of bortezomib, which is a research and development drug product. Bortezomib intermediate I is an impurity standard for bortezomib. Bortezomib intermediate I can be synthesized from the corresponding compound. It is an analytical standard used in pharmacopoeia and can be used as an API impurity or synthetic material in drug development. Bortezomib intermediate I has a high purity, natural origin, and a niche application. CAS No. 1248339-44-7

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
481.4 g/mol
Formula:
C25H36BN5O4
Purity:
Min. 95%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-II160938 Bortezomib intermediate I

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".